// App-Quantinova.ai

: Changes in Inflammation and Coagulation Markers in Patients with Thrombotic Primary Antiphospholipid Syndrome Treated with Hydroxychloroquine

Researchers

Presenter

  • F.T. Arantes

Principal Investigators

  • B.M. Mazetto

  • L.Q. Tobaldini

  • S.S. Saraiva

  • C. Vaz

  • A.P. Santos

  • J. Annichino-Bizzachi

  • F.A. Orsi

Medical Centers

  • University of Campinas (UNICAMP), School of Medical Science, Campinas, Brazil

  • University of Campinas - SP, Campinas, Brazil

  • University of Campinas, Hematology and Hemotherapy Center, Campinas, Brazil

Locations

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Antiphospholipid syndrome

  • Venous thrombosis

Biomarkers

  • C reactive protein

  • Tumor necrosis factor

  • von Willebrand factor

Drug/Treatment

  • Hydroxychloroquine

  • Interferon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved